Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Mar 24 2025
Mar 14 2026
Feb 21 2026
Jan 20 2026
Apr 18 2026